PROTEASE-RESISTANT PEPTIDE LIGANDS
    4.
    发明申请
    PROTEASE-RESISTANT PEPTIDE LIGANDS 审中-公开
    抗蛋白肽配体

    公开(公告)号:US20160159859A1

    公开(公告)日:2016-06-09

    申请号:US14904715

    申请日:2014-07-15

    CPC classification number: C07K7/06 C07K1/22 C07K7/08 C07K16/065

    Abstract: This invention relates generally to the discovery of novel protease-resistant peptide ligands and uses thereof. Specifically, the present invention provides a protease-resistant peptide with three to twenty amino acids capable of binding a biological and comprising one or more basic amino acid(s) and I or aromatic amino acids, wherein one or more of the amino acids is substituted with a non-naturally occurring amino acid analog.

    Abstract translation: 本发明一般涉及新蛋白酶抗性肽配体的发现及其用途。 具体地说,本发明提供一种能够结合生物学并含有一个或多个碱性氨基酸和I或芳族氨基酸的3-20个氨基酸的蛋白酶抗性肽,其中一个或多个氨基酸被取代 与非天然存在的氨基酸类似物。

    PRION PROTEIN LIGANDS AND METHODS OF USE
    8.
    发明申请
    PRION PROTEIN LIGANDS AND METHODS OF USE 审中-公开
    PRION蛋白配体及其使用方法

    公开(公告)号:US20140206021A1

    公开(公告)日:2014-07-24

    申请号:US14069052

    申请日:2013-10-31

    Abstract: Ligands that bind to prion proteins and methods for using the ligands for detecting or removing a prion protein from a sample, such as a biological fluid or an environmental sample. The ligands are capable of binding to one or more forms of prion protein including cellular prion protein (PrPc), infectious prion protein (PrPsc), and recombinant prion protein (PrPr). Prions from various species, including humans and hamsters, are bound by the ligands. Also provided is a method of treating or retarding the development of a prion-associated pathology in a subject

    Abstract translation: 与朊病毒蛋白结合的配体和使用配体检测或从样品例如生物液体或环境样品中除去朊病毒蛋白的方法。 配体能够结合一种或多种形式的朊病毒蛋白,包括细胞朊蛋白(PrPc),感染性朊病毒蛋白(PrPsc)和重组朊蛋白(PrPr)。 来自各种物种的朊病毒,包括人类和仓鼠,都被配体结合。 还提供了治疗或延缓受试者中朊病毒相关病理学发展的方法

Patent Agency Ranking